Protective association of the ε2/ε3 heterozygote with Alzheimer's disease is strengthened by TOMM40–APOE variants in men
- 26 July 2021
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 17 (11) , 1779-1787
Abstract
Introduction: Despite advances, understanding the protective role of the apolipoprotein E (APOE) ε2 allele in Alzheimer's disease (AD) remains elusive.Methods: We examined associations of variants comprised of the TOMM40 rs8106922 and APOE rs405509, rs440446, and ε2‐encoding rs7412 polymorphisms with AD in a sample of 2862 AD‐affected and 169,516 AD‐unaffected non‐carriers of the ε4 allele.Results: Association of the ε2/ε3 heterozygote of men with AD is 38% (P = 1.65 × 10−2) more beneficial when it is accompanied by rs8106922 major allele homozygote and rs405509 and rs440446 heterozygotes than by rs8106922 heterozygote and rs405509 and rs440446 major allele homozygotes. No difference in the beneficial associations of these two most common ε2/ε3‐bearing variants with AD was identified in women. The role of ε2/ε3 heterozygote may be affected by different immunomodulation functions of rs8106922, rs405509, and rs440446 variants in a sex‐specific manner.Discussion: Combination of TOMM40 and APOE variants defines a more homogeneous AD‐protective ε2/ε3‐bearing profile in men.Keywords
Funding Information
- National Institute on Aging (R01 AG047310, R01 AG061853, R01 AG065477, R01 AG070488)
This publication has 65 references indexed in Scilit:
- Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOEJournal of Human Genetics, 2011
- APOE and Alzheimer disease: a major gene with semi-dominant inheritanceMolecular Psychiatry, 2011
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseNature Genetics, 2011
- Network medicine: a network-based approach to human diseaseNature Reviews Genetics, 2010
- ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recyclingProceedings of the National Academy of Sciences, 2010
- A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's diseaseThe Pharmacogenomics Journal, 2009
- APOE genotype-specific differences in the innate immune responseNeurobiology of Aging, 2009
- Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family StudyArchives of Neurology, 2008
- The human disease networkProceedings of the National Academy of Sciences, 2007
- Network biology: understanding the cell's functional organizationNature Reviews Genetics, 2004